HOME Top Market Reports HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020

HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: February 2016
Report Code: MD 4083

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The HPV testing and Pap test Market is estimated to grow at a CAGR of 6.6% to reach USD 4,523.1 Million by 2020.

Based on test type, the HPV testing market has been divided into two major segments, namely, HPV testing and Pap test. The HPV testing segment is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing. The Pap test segment is expected to account for the largest share of the market in 2015. But this segment is projected to decline at a negative during the forecast period due to due the shift towards the use of HPV testing, as it provides enhanced accuracy and sensitivity than Pap test. Furthermore, the HPV testing segment is expected to grow at the highest CAGR in the next five years, owing to increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.

Based on application, the global market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected to account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.

Based on end user, the market is classified into three segments, namely, hospitals, laboratories, physicians’ offices and clinics. The laboratories end-user segment is expected to account for the largest share of the HPV testing market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.

Based on geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2015, the HPV testing market is expected to be dominated by North America and expected to grow at highest CAGR during forecast period. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the North American region.

A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market. However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. In addition to this, the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing and Pap test market

Scope of the Report

  • The market size for countries in Europe and Rest of the World is not covered due to limited availability of data
  • The market study does not cover the country-wise market in terms of volume

Years considered for the study


Particular

Scope

Historical Year

2013

Base Year

2014

Estimated Year

2015

Projected Year

2020

Forecast Period

2015–2020

Revenue Currency

USD ($)

Market Segmentation

The HPV testing market is categorized into sub-segments on the basis of test types, application, end user and geographic region.

HPV testing and Pap test market, by test Type

  • HPV Testing
  • Follow-up HPV Testing
  • Co-testing
  • HPV Primary testing
  • Pap Test

HPV testing and Pap test market, by Application

  • Pap Test
  • Cervical Cancer Screening
  • Vaginal Cancer Screening

HPV testing and Pap test Market, by End User

  • Laboratories
  • Hospitals
  • Physician’s Offices & Clinics

HPV testing and Pap test market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia-Pacific
    • Japan
    • India
    • China
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 HPV testing Market Size Estimation
    2.2 HPV testing Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 26)
    4.1 Market Overview
    4.2 Market, By Test Type
    4.3 Market, By Test Type and End User
    4.4 Market, By Region

5 Market Overview (Page No. - 28)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing Number of Cervical Cancer Cases and Growing Aging Population
                    5.3.1.2 Increasing Awareness of Cervical Cancer Screening Programs
                    5.3.1.3 Government Initiatives and Funding
           5.3.2 Restraints
                    5.3.2.1 Changes in Regulatory Guidelines for Cervical Cancer Screening
                    5.3.2.2 HPV Vaccination
           5.3.3 Opportunity
                    5.3.3.1 Introduction of HPV Primary Screening Tests
           5.3.4 Challenge
                    5.3.4.1 Uncertain Reimbursement Scenario

6 HPV Testing and PAP Test Market, By Test Type (Page No. - 37)
    6.1 Introduction
    6.2 HPV Testing
    6.3 Follow-Up HPV Testing
    6.4 Co-Testing
    6.5 Primary HPV Testing
    6.6 PAP Test

7 PAP Test Market, By Application (Page No. - 47)
    7.1 Introduction
           7.1.1 Cervical Cancer Screening
           7.1.2 Vaginal Cancer Screening

8 HPV Testing and PAP Test Market, By End User (Page No. - 53)
    8.1 Introduction
    8.2 Laboratories
    8.3 Hospitals
    8.4 Physicians’ Offices and Clinics

9 HPV Testing and PAP Test Market, By Region (Page No. - 61)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 92)
     10.1 Overview
     10.2 Market Share Analysis, Global HPV testing Market
             10.2.1 Product Approvals and Licenses
             10.2.2 New Product Launches
             10.2.3 Agreements, Collaborations, and Partnerships
             10.2.4 Acquisitions
             10.2.5 Expansions

11 Company Profile (Page No. - 100)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Introduction
     11.2 Abbott Laboratories
     11.3 Qiagen N.V.
     11.4 Roche Diagnostics
     11.5 Hologic, Inc.
     11.6 Becton, Dickinson and Company
     11.7 Quest Diagnostics
     11.8 Onco Health Corporation
     11.9 Seegene, Inc.
     11.10 Femasys Inc.
     11.11 Arbor Vita Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 120)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports


List of Tables (80 Tables)

Table 1 Increasing Number of Cervical Cancer Cases and Growing Aging Population Drive the HPV testing Market
Table 2 Changes in Regulatory Guidelines for Cervical Cancer Screening Acts A Restraining Factor Hampering the Market Growth
Table 3 Introduction of HPV Primary Screening Tests Provide Significant Growth Opportunities for the HPV testing Market
Table 4 Uncertain Reimbursement Scenario is Limiting the Growth for the PAP Test Market
Table 5 HPV testing Market Size, By Test Type, 2013–2020 (USD Million)
Table 6 Market Size, By Test Type, 2013–2020 (Million Tests)
Table 7 Market Size, By Test Type, 2013–2020 (USD Million)
Table 8 Market Size, By Region, 2013–2020 (USD Million)
Table 9 Market Size, By Region, 2013–2020 (Million Tests)
Table 10 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 11 Asia-Pacific: Market Size, By Country, 2013–2020 (USD Million)
Table 12 Follow-Up HPV Testing Market Size, By Region, 2013–2020 (USD Million)
Table 13 HPV Co-Testing Market Size, By Region, 2013–2020 (USD Million)
Table 14 Market Size, By Region, 2013–2020 (USD Million)
Table 15 Market Size, By Region, By Volume 2013–2020 (Million Tests)
Table 16 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 17 Asia-Pacific: Market Size, By Country, 2013–2020 (USD Million)
Table 18 Market Size, By Application, 2013–2020 (USD Million)
Table 19 Cervical Cancer Screening Market Size, By Region, 2013–2020 (USD Million)
Table 20 North America: Cervical Cancer Screening Market Size, By Country, 2013–2020 (USD Million)
Table 21 Asia-Pacific: Cervical Cancer Screening Market Size, By Country, 2013–2020 (USD Million)
Table 22 Vaginal Cancer Screening Market Size, By Country, 2013–2020 (USD Million)
Table 23 Asia-Pacific: Vaginal Cancer Screening Market Size, By Country, 2013–2020 (USD Million)
Table 24 Market Size, By End User, 2013–2020 (USD Million)
Table 25 Market Size for Laboratories, By Region, 2013–2020 (USD Million)
Table 26 North America: Market Size for Laboratories, By Country, 2013–2020 (USD Million)
Table 27 Asia-Pacific: Market Size for Laboratories, By Country, 2013–2020 (USD Million)
Table 28 Market Size for Hospitals, By Region, 2013–2020 (USD Million)
Table 29 North America: Market Size for Hospitals, By Country, 2013–2020 (USD Million)
Table 30 Asia-Pacific: Market Size for Hospitals, By Region/Country, 2013–2020 (USD Million)
Table 31 Market Size for Physician’s Offices and Clinics, By Region, 2013–2020 (USD Million)
Table 32 North America: Market Size for Physician’s Offices and Clinics, By Country, 2013–2020 (USD Million)
Table 33 Asia-Pacific: Market Size for Physician’s Offices and Clinics, By Country, 2013–2020 (USD Million)
Table 34 Market Size, By Region, 2013–2020 (USD Million)
Table 35 Market Size, By Region, 2013–2020 (Million Tests)
Table 36 North America: HPV Testing Market Size, By Country, 2013–2020 (USD Million)
Table 37 North America: Market Size, By Test Type, 2013–2020 (USD Million)
Table 38 North America: Market Size, By Test Type, 2013–2020 (Million Tests)
Table 39 North America: Market Size, By Test Type, 2013–2020 (USD Million)
Table 40 North America: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 41 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 42 U.S.: Market Size, By Test Type, 2013–2020 (USD Million)
Table 43 U.S.: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 44 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 45 Canada: Market Size, By Test Type, 2013–2020 (USD Million)
Table 46 Canada: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 47 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 48 Europe: Market Size, By Test Type, 2013–2020 (USD Million)
Table 49 Europe: Market Size, By Test Type, 2013–2020 (Million Tests)
Table 50 Europe: Market Size, By Test Type, 2013–2020 (USD Million)
Table 51 Europe: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 52 Europe: PAP Test Market Size, By End User, 2013–2020 (USD Million)
Table 53 Asia-Pacific: PAP Test Market Size, By Country, 2013–2020 (USD Million)
Table 54 Asia-Pacific: PAP Test Market Size, By Test Type, 2013–2020 (USD Million)
Table 55 Asia-Pacific: PAP Test Market Size, By Test Type, 2013–2020 (Million Tests)
Table 56 Asia-Pacific: Market Size, By Test Type, 2013–2020 (USD Million)
Table 57 Asia-Pacific: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 58 Asia-Pacific: PAP Test Market Size, By End User, 2013–2020 (USD Million)
Table 59 Japan: PAP Test Market Size, By Test Type, 2013–2020 (USD Million)
Table 60 Japan: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 61 Japan: PAP Test Market Size, By End User, 2013–2020 (USD Million)
Table 62 China: PAP Test Market Size, By Test Type, 2013–2020 (USD Million)
Table 63 China: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 64 China: Market Size, By End User, 2013–2020 (USD Million)
Table 65 India: Market Size, By Test Type, 2013–2020 (USD Million)
Table 66 India: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 67 India: HPV Testing Market Size, By End User, 2013–2020 (USD Million)
Table 68 RoAPAC: HPV Testing Market Size, By Test Type, 2013–2020 (USD Million)
Table 69 RoAPAC: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 70 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
Table 71 RoW: Market Size, By Test Type, 2013–2020 (USD Million)
Table 72 RoW: Market Size, By Test Type, 2013–2020 (Million Tests)
Table 73 RoW: HPV Testing Market Size, By Test Type, 2013–2020 (USD Million)
Table 74 RoW: PAP Test Market Size, By Application, 2013–2020 (USD Million)
Table 75 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 76 Product Approvals and Licenses 2013-2015
Table 77 New Product Launches, 2012–2015
Table 78 Agreements, Collaborations, and Partnerships, 2012–2015
Table 79 Acquisitions, 2012–2015
Table 80 Expansions, 2012–2015


List of Figures (52 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation and Data Triangulation
Figure 3 Breakdown of Primary Interviews: By Companies, Designation, and Region
Figure 4 Market Snapshot (2015 vs 2020)
Figure 5 Market, By Test Type, 2015 vs 2020
Figure 6 The Hospitals Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 7 Cervical Cancer Screening Segment Will Continue to Dominate the PAP Test Market During the Forecast Period
Figure 8 New Product Launch is the Most Dominant Strategy Adopted By Market Players
Figure 9 Rising Incidences of Cervical Cancer and Increasing Awareness of Cervical Cancer Screening are Factors Driving Market Growth
Figure 10 HPV Testing Will Be the Fastest-Growing Segment During the Forecast Period
Figure 11 Laboratories Segment Dominates the HPV Testing Market in 2015
Figure 12 The HPV Testing and PAP Test Market in North America is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 13 Market Analysis
Figure 14 Market: Drivers, Restraints, Opportunity, and Challenge
Figure 15 Cervical Cancer Incidences and Mortality: Global Forecast, 2012-2020
Figure 16 HPV Testing Segment to Outgrow PAP Testing During the Forecast Period
Figure 17 Primary HPV Testing Segment is Expected to Grow at the Highest CAGR During Forecast Period
Figure 18 North America is Projected to Dominate the HPV Testing Market During Forecast Period
Figure 19 North America is Expected to Dominate the PAP Test Market During the Forecast Period
Figure 20 Cervical Cancer Screening is A Major Application of the Market
Figure 21 North America is Expected to Dominate the PAP Test Market for Cervical Cancer Screening
Figure 22 North America is Expected to Dominate the Vaginal Cancer Screening Market
Figure 23 Laboratories are the Major End Users of the HPV Testing Market
Figure 24 North America Exhibits Highest Growth Potential in the Laboratories End User Segment
Figure 25 North America is Projected to Dominate the Hospitals Market During the Forecast Period
Figure 26 North America: Highest Growth Potential in the Physicians’ Offices and Clinics End-User Segment
Figure 27 Geographic Snapshot: North America Will Be the Fastest-Growing Region in the HPV Testing Market By 2020
Figure 28 North American Market for HPV Testing Shows Significant Growth Opportunities
Figure 29 The HPV Testing Market in North America is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America HPV Testing Market Snapshot
Figure 31 The U.S. is Expected to Grow at the Highest CAGR in the North America HPV Testing Market During the Forecast Period
Figure 32 The Follow-Up HPV Testing Segment is Expected to Dominate the North America HPV Testing Market
Figure 33 The Hospitals Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 34 The HPV Testing Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 35 European HPV Testing Market Snapshot
Figure 36 The Hospitals Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 37 Japan is Estimated to Account for the Largest Share in the Asia-Pacific HPV Testing Market
Figure 38 The Laboratories Segment Accounted for the Largest Share in 2015
Figure 39 The Cervical Cancer Screening Segment Accounted for the Largest Share in 2015
Figure 40 The HPV Testing Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 41 The Hospitals Segment is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 42 The Hospitals Segment is Expected to Grow at the Highest CAGR During The Forecast Period
Figure 43 New Product Launches, Product Approvals, Agreements, and Acquisitions Have Been the Key Strategies Adopted in the Last Three Years
Figure 44 Global HPV Testing Market Share, By Key Players, 2014
Figure 45 Battle for Market Share: Product Approvals and Licenses, New Product Launch, Agreements & Acquisitions Have Been the Key Strategies
Figure 46 Geographic Revenue Mix of the Top Five Market Players
Figure 47 Abbott Laboratories: Company Snapshot
Figure 48 Qiagen N.V.: Company Snapshot
Figure 49 Roche Diagnostics: Company Snapshot
Figure 50 Hologic, Inc.: Company Snapshot
Figure 51 Becton, Dickinson and Company: Company Snapshot
Figure 52 Quest Diagnostics: Company Snapshot

The HPV testing and Pap test market is expected to grow at a CAGR of 6.6% to reach USD 4,523.1 Million by 2020. A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing market. However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. In addition to this, the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.

HPV testing market is divided into two major segments on the basis of test type, namely, HPV testing. Follow-up HPV testing, co-testing, HPV primary testing are three sub-segments of HPV testing. The Pap test segment is expected to account for the largest share of the HPV testing market in 2015. HPV testing segment is expected to grow at the highest CAGR in the next five years owing to increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.

On the basis of type of application, the global HPV testing market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected to account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about the benefits of cervical cancer screening.

Pap test market is classified into three segments on basis of end users, namely, hospitals, laboratories, physicians’ offices and clinics. The laboratories end-user segment is expected account for the largest share of the Pap test market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing market.

HPV Testing & Pap Test Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo